Literature DB >> 11239202

Anticonvulsant lamotrigine administered on reperfusion fails to improve experimental stroke outcomes.

R J Traystman1, J A Klaus, A C DeVries, A B Shaivitz, P D Hurn.   

Abstract

BACKGROUND AND
PURPOSE: Recent results suggest that selective inhibitors of presynaptic neuronal ion channels can diminish glutamate release during cerebral ischemia and modulate excitotoxic cell death. The aim of the present study was to evaluate lamotrigine (LTG), an antiepileptic that inhibits presynaptic sodium and voltage-sensitive calcium channels, as a potential stroke resuscitation agent in the rat. Three dosages of LTG were examined for effect on infarction volume and sensorimotor behavioral recovery after middle cerebral artery (MCA) occlusion.
METHODS: Halothane-anesthetized male Wistar rats were subjected to 2 hours of MCA occlusion by the intraluminal occlusion technique. Physiological variables were controlled, and ipsilateral cortical perfusion was monitored by laser Doppler flowmetry throughout ischemia. At onset of reperfusion, rats received intravenous LTG 5, 10, or 20 mg/kg or PBS (n=9 to 11 per group) during 15 minutes. Behavioral assessment was completed at 3 and 7 days after stroke, and the brain was harvested for histology (triphenyltetrazolium chloride staining).
RESULTS: Values are mean+/-SE. Cortical infarction volumes were unchanged in LTG-treated animals: 14+/-6% of contralateral cortex at 5 mg/kg LTG, 17+/-7% at 10 mg/kg, and 30+/-6% at 20 mg/kg, versus saline-treated cohorts (12+/-3%; P:=0.19; n=9). Caudate-putamen infarction injury was also unchanged (37+/-11% of contralateral caudate-putamen at 5 mg/kg LTG, 44+/-8% at 10 mg/kg, and 65+/-9% at 20 mg/kg versus saline (38+/-11%; P:=0.18). Total infarction was not different among groups (P:=0.15). Consistent with histology, behavioral outcomes were unimproved by treatment.
CONCLUSIONS: Histological damage and behavioral recovery at 7 days after MCA occlusion was not altered by LTG treatment over the dosage range used in the present study.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239202     DOI: 10.1161/01.str.32.3.783

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  6 in total

Review 1.  Clinical trials for cytoprotection in stroke.

Authors:  Lise A Labiche; James C Grotta
Journal:  NeuroRx       Date:  2004-01

2.  Lamotrigine Attenuates Proteasome Inhibition-Induced Apoptosis by Suppressing the Activation of the Mitochondrial Pathway and the Caspase-8- and Bid-Dependent Pathways.

Authors:  Yoon Jeong Nam; Arum Kim; Min Sung Lee; Yong Kyoo Shin; Dong Suep Sohn; Chung Soo Lee
Journal:  Neurochem Res       Date:  2016-05-26       Impact factor: 3.996

3.  Migraine prophylaxis, ischemic depolarizations, and stroke outcomes in mice.

Authors:  Katharina Eikermann-Haerter; Jeong Hyun Lee; Nilufer Yalcin; Esther S Yu; Ali Daneshmand; Ying Wei; Yi Zheng; Anil Can; Buse Sengul; Michel D Ferrari; Arn M J M van den Maagdenberg; Cenk Ayata
Journal:  Stroke       Date:  2014-11-25       Impact factor: 7.914

Review 4.  Glutamate receptors, neurotoxicity and neurodegeneration.

Authors:  Anthony Lau; Michael Tymianski
Journal:  Pflugers Arch       Date:  2010-03-14       Impact factor: 3.657

Review 5.  Treatment of acute cerebral ischemia using animal models: a meta-analysis.

Authors:  Peng-Fei Wang; Yu Zhou; Huang Fang; Sen Lin; Yan-Chun Wang; Yong Liu; Jun Xia; Guy D Eslick; Qing-Wu Yang
Journal:  Transl Neurosci       Date:  2015-02-11       Impact factor: 1.757

6.  Electroacupuncture induces acute changes in cerebral cortical miRNA profile, improves cerebral blood flow and alleviates neurological deficits in a rat model of stroke.

Authors:  Hai-Zhen Zheng; Wei Jiang; Xiao-Feng Zhao; Jing Du; Pan-Gong Liu; Li-Dan Chang; Wen-Bo Li; Han-Tong Hu; Xue-Min Shi
Journal:  Neural Regen Res       Date:  2016-12       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.